Q3 2024 Holdings
Filed 2024-11-14 | 443 holdings | $6.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $2.0B | 19,991,024 | 30.6% |
| Viatris Inc(VTRS) | COM | 92556V106 | $278.6M | 23,993,023 | 4.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $199.7M | 2,652,189 | 3.0% |
| Merus N V | COM | N5749R100 | $170.3M | 3,408,539 | 2.5% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $166.5M | 7,851,675 | 2.5% |
| Integra Lifesciences Hldgs C | NOTE 0.500% 8/1 | 457985AM1 | $165.8M | $174,364,000 | 2.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $160.6M | 11,077,927 | 2.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $151.7M | 1,316,590 | 2.3% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $139.1M | 21,231,974 | 2.1% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $138.1M | 4,952,004 | 2.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $132.1M | 2,912,692 | 2.0% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $128.3M | 10,854,985 | 1.9% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $123.8M | 6,229,634 | 1.9% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $122.0M | $132,598,000 | 1.8% |
| Alnylam Pharmaceuticals Inc | NOTE 1.000% 9/1 | 02043QAB3 | $117.1M | $100,000,000 | 1.7% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $109.1M | 9,711,410 | 1.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $106.0M | 15,612,264 | 1.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $105.7M | 5,411,571 | 1.6% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $105.7M | $117,500,000 | 1.6% |
| Mirum Pharmaceuticals Inc | NOTE 4.000% 5/0 | 604749AB7 | $103.0M | $70,000,000 | 1.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $82.2M | 2,594,000 | 1.2% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $77.1M | 4,911,979 | 1.2% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $73.0M | 1,923,100 | 1.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $61.8M | 8,135,804 | 0.9% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $57.4M | 1,780,287 | 0.9% |
| CVS Health Corp(CVS) | COM | 126650100 | $55.0M | 874,800 | 0.8% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $54.9M | 3,280,000 | 0.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $50.7M | 151,575 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $50.3M | 1,023,265 | 0.8% |
| Indivior PLC(INDV) | ORD | G4766E116 | $49.7M | 5,092,642 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $47.5M | 1,781,006 | 0.7% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $45.7M | 1,795,174 | 0.7% |
| Conmed Corp(CNMD) | COM | 207410101 | $44.2M | 614,890 | 0.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $40.6M | 1,411,000 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $40.4M | 3,744,263 | 0.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $39.9M | 145,000 | 0.6% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $39.5M | 4,997,746 | 0.6% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $39.3M | $25,255,000 | 0.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $38.5M | 2,730,343 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $37.6M | 2,031,700 | 0.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $37.6M | 2,817,763 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $37.1M | 844,407 | 0.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $36.5M | 2,617,713 | 0.5% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $34.1M | 1,508,943 | 0.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $32.1M | 850,695 | 0.5% |
| Docgo Inc(DCGO) | COM | 256086109 | $30.1M | 9,066,138 | 0.4% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $28.2M | 3,027,886 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $27.6M | 6,710,429 | 0.4% |
| Savara Inc(SVRA) | COM | 805111101 | $27.4M | 6,465,777 | 0.4% |
| Inmode LTD(INMD) | SHS | M5425M103 | $26.8M | 1,578,708 | 0.4% |